Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-09-29

Clinical Trial Update: Intraabdominal Chloroprocaine During Cesarean Delivery for Pain Control [Phase 3]

View source ↗

Summary

Phase 3 trial on intraabdominal chloroprocaine for pain control during cesarean delivery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroprocaine (Chloroprocaine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cesarean Section Complications, Pain | Phase 3 | Status: WITHDRAWN